Featured
-
-
Brief Communication |
Associating CYP2A6 structural variants with ovarian and lung cancer risk in the UK Biobank: replication and extension
- Alec W. R. Langlois
- , Jennie G. Pouget
- & Rachel F. Tyndale
-
Article
| Open Access
The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23—a likely pathogenic variant with reduced penetrance?
- Hildegunn Høberg-Vetti
- , Elisabet Ognedal
- & Per Morten Knappskog
-
Article |
Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer
- Erin Tutty
- , Lara Petelin
- & Laura E. Forrest
-
Article |
The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?
- Natalia Teixeira
- , Annemieke van der Hout
- & Geertruida H. de Bock
-
Article
| Open Access
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers
- Logan C Walker
- , Louise Marquart
- & Amanda B Spurdle
-
Article
| Open Access
BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study
- Hildegunn Høberg-Vetti
- , Cathrine Bjorvatn
- & Nicoline Hoogerbrugge
-
Article |
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes
- Laurent Castéra
- , Sophie Krieger
- & Dominique Vaur
-
Article |
DNA polymorphism and epigenetic marks modulate the affinity of a scaffold/matrix attachment region to the nuclear matrix
- Natalia P Kisseljova
- , Petr Dmitriev
- & Yegor S Vassetzky
-
News and Commentary |
Do BRCA1/2 mutations and low FMR1 alleles interact or not?
- Norbert Gleicher
- , Andrea Weghofer
- & David H Barad
-
Short Report |
The FMR1 CGG repeat test is not a candidate prescreening tool for identifying women with a high probability of being carriers of BRCA mutations
- Maria Teresa Ricci
- , Loredana Pennese
- & Liliana Varesco
-
Article
| Open Access
Kernel canonical correlation analysis for assessing gene–gene interactions and application to ovarian cancer
- Nicholas B Larson
- , Gregory D Jenkins
- & Brooke L Fridley
-
Article |
PGD for hereditary breast and ovarian cancer: the route to universal tests for BRCA1 and BRCA2 mutation carriers
- Marion Drüsedau
- , Jos C Dreesen
- & Aimée D Paulussen
-
Short Report |
MED12 exon 2 mutations in histopathological uterine leiomyoma variants
- Netta Mäkinen
- , Pia Vahteristo
- & Lauri A Aaltonen
-
Short Report |
Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families
- Gorka Ruiz de Garibay
- , Avellaneda Díaz
- & Miguel de la Hoya
-
Short Report |
Genome-wide paternal uniparental disomy mosaicism in a woman with Beckwith–Wiedemann syndrome and ovarian steroid cell tumour
- Magdalena Gogiel
- , Matthias Begemann
- & Gertrud Strobl-Wildemann
-
Article |
Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec
- Michel Dorval
- , Catherine Noguès
- & Claire Julian-Reynier
-
Short Report |
Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters
- Jacqueline M Vink
- , Folkert J van Kemenade
- & Dorret I Boomsma
Genome, HLA and polygenic risk score analyses for prevalent and persistent cervical human papillomavirus (HPV) infections